Robotic-Assisted System in Enhancing Balance, Postural Stability, Functional Gait and Fall Efficacy in Older Adults
Launched by GULF MEDICAL UNIVERSITY · May 7, 2025
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new robotic system designed to help older adults improve their balance and walking skills, which can reduce the risk of falls. The Hunova Robotic System offers personalized exercises that are tailored to each person's specific needs, compared to more general balance exercises that many people might be familiar with. By using this advanced technology, the researchers hope to see better results in enhancing balance, stability, and walking abilities among older adults.
To participate in this trial, you need to be between 65 and 85 years old and able to walk independently, even if you need a little help. You should also have a good understanding of instructions. However, if you have certain medical conditions or are currently undergoing other balance training, you may not be eligible. If you join the study, you can expect to engage in specially designed exercises using the robotic system, which may provide you with valuable feedback and support as you work on your balance and mobility.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 60 years old to 85 years old - young to Old Individuals.
- • Mini Mental Scale Examination Score \> 24.
- • Able to walk independently with and without mild assistance (Berg's Balance Score between 35 and 45)
- Exclusion Criteria:
- • Unable to understand and follow instructions.
- • History of vestibular dysfunction.
- • Any severe Musculoskeletal problems restricting mobility.
- • Current Physiotherapy training or balance exercises focusing on proprioception or fall risk.
About Gulf Medical University
Gulf Medical University (GMU) is a prestigious academic institution located in the United Arab Emirates, dedicated to advancing healthcare through innovative education and research. As a leading clinical trial sponsor, GMU focuses on enhancing medical knowledge and improving patient outcomes by conducting rigorous and ethically sound clinical studies. The university fosters collaborations with local and international healthcare organizations, ensuring adherence to the highest standards of clinical research. With a commitment to excellence in medical education and research, GMU plays a pivotal role in the development and evaluation of new therapeutic interventions and medical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ajman, , United Arab Emirates
Patients applied
Trial Officials
Meruna Bose, PHD
Study Chair
Gulf Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported